Artificial pancreas will be piloted in 1,000 diabetics, says...

NHS England will provide artificial pancreas devices to 1,000 type 1 diabetes patients as part of a pilot study of the technology, according to chief executive Sir Simon Stevens.

Study finds "alarming" hike in antidepressant costs during C...

Researchers in the UK have found that there was a four million rise in prescriptions for antidepressants in England during 2020, adding £139 million to NHS costs.

2021 - UK market access prospects

With a new year comes the opportunity to think ahead for the market access landscape for the coming year.

Takeda’s bleeding disorder drug Veyvondi backed for NHS use

NHS England has recommended that patients with von Willebrand disease (VWD) be treated with Takeda’s Veyvondi, making it the first and only medicine backed for what is the most common inher

NHS digital health unit looks for remote monitoring tech in ...

The NHS digital health unit NHSX is looking for suppliers of remote monitoring technology as it tries to find large-scale solutions during the COVID-19 pandemic.

Novartis strikes landmark deal with NHS to speed up inclisir...